---
title: "Biogen Inc. Stock Underperforms Monday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293254152.md"
description: "Biogen Inc. (BIIB) shares fell 2.93% to $199.95 on Monday, underperforming competitors like Johnson & Johnson, Pfizer, and AbbVie during a broader market decline. This marks the second consecutive day of losses for Biogen, which remains 9% below its 52-week high. Trading volume was notably lower than the 50-day average."
datetime: "2026-07-20T20:58:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293254152.md)
  - [en](https://longbridge.com/en/news/293254152.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293254152.md)
generator: "portal-rs"
---

# Biogen Inc. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Biogen Inc. (BIIB) slipped 2.93% to $199.95 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.19% to 7,443.28 and Dow Jones Industrial Average falling 0.59% to 51,839.26.

This was the stock's second consecutive day of losses.

Biogen Inc. closed 9.00% short of its 52-week high of $219.72, which the company achieved on June 29th.

The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 1.67% to $248.82, Pfizer Inc. (PFE) fell 1.20% to $24.75, and AbbVie Inc. (ABBV) fell 0.44% to $253.38.

Trading volume (962,629) remained 342,178 below its 50-day average volume of 1.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 20, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-20-26 1658ET

### Related Stocks

- [BIIB.US](https://longbridge.com/en/quote/BIIB.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [4,582 Shares in Biogen Inc. $BIIB Purchased by EFG International AG](https://longbridge.com/en/news/297145391.md)
- [Biogen platforms lupus patient advocate in social media push](https://longbridge.com/en/news/297335137.md)
- [Biogen CEO Viehbacher to speak at Morgan Stanley Global Healthcare Conference](https://longbridge.com/en/news/297227566.md)
- [Great Lakes Advisors LLC Takes Position in Biogen Inc. $BIIB](https://longbridge.com/en/news/296676602.md)
- [Biogen: LEQEMBI IQLIK Autoinjector Available In U.S. For Early Alzheimer's](https://longbridge.com/en/news/296787337.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**